Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.04 - Poster Session 1 - Tumor Immunology
- Type: Poster Session
- Track: Biology
- Presentations: 1
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.04-001 - Combining Prime-Boost Anti-tumour Vaccination with Debulking Surgery for the Treatment of Malignant Mesothelioma
09:30 - 09:30 | Author(s): S. Fisher
- Abstract
Loading...
-
+
P1.05 - Poster Session 1 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 25
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.05-020 - Identifying therapeutic targets for mesothelioma using siRNA
09:30 - 09:30 | Author(s): E. Sollis
- Abstract
Loading... -
+
P1.05-021 - Dual checkpoint blockade using anti-PD-1 and anti-CTLA4 combined with cisplatin chemotherapy is effective in a murine mesothelioma model
09:30 - 09:30 | Author(s): A. Khong
- Abstract
Loading...
-
+
P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.05-020 - Combined gemcitabine and anti-CTLA4 therapy to target residual tumour following partial debulking surgery in a mouse mesothelioma model
09:30 - 09:30 | Author(s): A. Khong
- Abstract
Loading... -
+
P2.05-021 - Molecular analysis of asbestos-induced mesotheliomas from SV40 TAg transgenic mice shows that they are highly concordant with human mesothelioma
09:30 - 09:30 | Author(s): C. Robinson
- Abstract
Loading...
-
+
P2.10 - Poster Session 2 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 52
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.10-041 - Optimising regulatory T cell (Treg) depletion in combination with chemotherapy for enhanced anti-tumour immunity
09:30 - 09:30 | Author(s): A.M. Cook
- Abstract
Loading...
-
+
P2.14 - Poster Session 2 - Mesothelioma
- Type: Poster Session
- Track: Mesothelioma
- Presentations: 15
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.14-004 - EORTC and CALGB prognostic models, but not neutrophil-to-lymphocyte ratio, are prognostic in unselected patients with newly diagnosed malignant mesothelioma
09:30 - 09:30 | Author(s): T. Meniawy
- Abstract
Loading...
-
+
P3.05 - Poster Session 3 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 22
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.05-020 - Strategies for the prevention of mesothelioma in MexTAg mice
09:30 - 09:30 | Author(s): C. Robinson
- Abstract
Loading...
-
+
MO19 - Lung Cancer Immunobiology
- Type: Mini Oral Abstract Session
- Track: Biology
- Presentations: 13
- Moderators:Y. Sekido
- Coordinates: 10/30/2013, 10:30 - 12:00, Bayside 201 - 203, Level 2
-
+
MO19.03 - The effects of epidermal growth factor (EGFR) receptor inhibitors on the immune system in patients with advanced non-small cell lung cancer (NSCLC)
10:40 - 10:45 | Author(s): T. Meniawy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MS24 - Mesothelioma Biology and Biomarkers
- Type: Mini Symposia
- Track: Mesothelioma
- Presentations: 5
- Moderators:B. Robinson
- Coordinates: 10/30/2013, 14:00 - 15:30, Bayside 104, Level 1
-
+
MS24.1 - A Tractable Animal Model of Mesothelioma
14:04 - 14:24 | Author(s): R. Lake
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
